Browsing Tag
Mass General Brigham
2 posts
Neurizon Therapeutics (ASX: NUZ) just crossed the threshold every ALS biotech dreams about. Now the hard part starts.
Neurizon Therapeutics (ASX: NUZ) doses first ALS patient in the HEALEY Platform Trial. What the Phase 2/3 design means for investors and the sector. Read more.
February 27, 2026
Microsoft partners with top medical institutions to revolutionise radiology with AI
Microsoft Corp. has unveiled collaborations with leading academic medical institutions Mass General Brigham, the University of Wisconsin School…
July 25, 2024